The goal of our study is to show whether pimobendan will improve heart function in cats with advanced heart disease and moderate to severe heart enlargement and dysfunction, specifically by increasing performance of the heart and increasing blood flow.
The purposes of this clinical trial are to 1) determine the efficacy of a daily oral supplement in reducing the severity of the clinical signs of moderate to severe canine atopic dermatitis - AD (environmental allergies) and, 2) examine the difference in the percentage of days when anti-itching supplementation is needed to control flares in your dog's allergies.